Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Automated noteCorbus Pharmaceuticals filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Bally's Corp (0001747079) (Filer)
Automated noteBally's Corp filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, other events, and accompanying financial statements and exhibits.
- 8-K - FLOWSERVE CORP (0000030625) (Filer)
Automated noteFlowserve Corp filed a Form 8-K on September 14, 2026, reporting director and officer departures, elections, appointments and related compensation arrangements, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - HAIN CELESTIAL GROUP INC (0000910406) (Filer)
Automated noteHain Celestial Group Inc. filed a Form 8-K on September 14, 2026 reporting a material definitive agreement, its recent operating results and financial condition, changes to directors and officers, and accompanying financial statements and exhibits.
- 8-K - Brookfield Asset Management Ltd. (0001937926) (Filer)
Automated noteBrookfield Asset Management Ltd. filed a Form 8-K on September 14, 2026 (Accession No. 0001171843-26-006022, 215 KB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - TOYOTA MOTOR CREDIT CORP (0000834071) (Filer)
Automated noteToyota Motor Credit Corp filed a Form 8-K on September 14, 2026, reporting a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - American Healthcare REIT, Inc. (0001632970) (Filer)
Automated noteAmerican Healthcare REIT, Inc. filed a Form 8-K on September 14, 2026, providing a Regulation FD disclosure under Item 7.01.
- 8-K - STATE STREET CORP (0000093751) (Filer)
Automated noteState Street Corp filed a Form 8-K on September 14, 2026, disclosing departures, elections or appointments of directors and certain officers along with related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - ADDENTAX GROUP CORP. (0001650101) (Filer)
Automated noteAddentax Group Corp. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, and the inclusion of its financial statements and related exhibits.
- 8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
Automated notePerspective Therapeutics, Inc. filed a Form 8-K with the SEC on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Lipocine Inc. (0001535955) (Filer)
Automated noteLipocine Inc. filed a Form 8-K on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Embrace Change Acquisition Corp. (0001869601) (Filer)
Automated noteEmbrace Change Acquisition Corp filed a Form 8-K indicating it has entered into a material definitive agreement, as disclosed in Item 1.01 of the filing.
- 8-K - WhiteFiber, Inc. (0002042022) (Filer)
Automated noteWhiteFiber, Inc. filed a Form 8-K on September 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - ORACLE CORP (0001341439) (Filer)
Automated noteOracle Corp filed a Form 8-K on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Artificial Intelligence Technology Solutions Inc. (0001498148) (Filer)
Automated noteArtificial Intelligence Technology Solutions Inc. filed a Form 8-K on September 14, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- Isabel Schnabel: Macroeconomic, fiscal and financial stability in a shock-prone world
Automated noteECB member Isabel Schnabel highlighted the challenges to macroeconomic, fiscal and financial stability in a world prone to shocks.
- Japanese Government Bonds Held by the Bank of Japan
Automated noteThe Bank of Japan reports its holdings of Japanese government bonds.
- Japanese Government Bonds Held by the Bank of Japan
Automated noteThe Bank of Japan disclosed the current level of Japanese Government Bonds it holds, providing figures for total holdings and their breakdown by issue type.
- IMES Discussion Paper Series (2026)
Automated noteThe Bank of Japan released the 2026 edition of its IMES Discussion Paper Series.
- IMES Discussion Paper Series (2026)
Automated noteThe Bank of Japan published the 2026 IMES Discussion Paper Series.
- Bank of Japan Accounts (September 10)
Automated noteThe Bank of Japan published its September 10 accounts, presenting its financial statements and balance sheet for the reporting period.
- Bank of Japan Accounts (September 10)
Automated noteThe Bank of Japan released its Accounts data on September 10.
- Presidential Message on the Anniversary of the Battle of Fort McHenry
Automated noteThe White House released a presidential message commemorating the anniversary of the 1814 Battle of Fort McHenry, noting the defense of Baltimore by American forces against a British naval bombardment during the War of 1812.
- Christine Lagarde: Interview with Ouest-France
Automated noteECB President Christine Lagarde gave an interview to the French newspaper Ouest-France.
- Christine Lagarde: Europe seen from Normandy
Automated noteECB President Christine Lagarde spoke about Europe during an appearance in Normandy.
- 8-K - Polaryx Therapeutics, Inc. (0002075320) (Filer)
Automated notePolaryx Therapeutics, Inc. filed a Form 8-K on September 14, 2026 (Accession No. 0001213900-26-099416) reporting Item 5.07, which details the submission of certain matters to a vote of its security holders.
- 8-K/A - BIOLARGO, INC. (0000880242) (Filer)
Automated noteBiolargo, Inc. filed an amended Form 8-K on September 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - abrdn Global Infrastructure Income Fund (0001793855) (Filer)
Automated noteabrdn Global Infrastructure Income Fund filed a Form 8-K on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - NorthStrive Acquisition Corp I. (0002133719) (Filer)
Automated noteNorthStrive Acquisition Corp I filed a Form 8-K with the SEC on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - BIOVIE INC. (0001580149) (Filer)
Automated noteBiovie Inc. filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.